remember Ct values? those numbers spit out by certain types of PCR tests, including some of the ones we use to test for the coronavirus?
let's talk. 1/
Ct values correlate with how much viral RNA is in the sample. so if you're running several samples on a test platform, and some have higher Cts, those have *less* RNA (it's a reverse scale; Cts count how many times you have to copy the genetic material before it's "visible") 2/
Ct values do not tell you if the viral RNA belongs to an intact virus or an infectious virus. they also don't measure how directly "transmissible" someone is. to measure transmission, we need epidemiological data - how are *actual humans* spreading the virus? 3/
two people who take the same test and get similar Ct values might not actually pass a virus on to equal extents. things that matter: state of the virus. state of the person - are they symptomatic? vaccinated? who are they interacting with? where? 4/
Ct values are useful, but not enough to draw big conclusions. take them with a grain of salt. 5/5
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The day this piece published, one of my own cats, Calvin, was diagnosed with a serious condition, likely with genetic roots, that impacts his heart function. There is no cure. We don't yet know his prognosis. I am absolutely heartbroken. 2/
We adopted Calvin and his brother, Hobbes, almost 5 years ago, to the day. Since then, they have both brought immeasurable light into my life, and have been my biggest source of comfort during the pandemic. 3/
If your antibody levels drop over time... it's not the end of the world. Actually, it's what happens naturally. It's expected. It's your body being economical with its resources. 1/
Think of it this way. Antibodies are ephemeral proteins. Individual antibodies aren't built to last forever. They'll ebb after an infectious threat has passed. But the body retains the capacity to produce them. 3/
Let's first get our definitions straight. Vaccines, first and foremost, prevent *illness*, especially of the serious sort. They teach the body to rein the virus in, and keep it from running roughshod over your tissues. It's harder, though, to stop infections entirely. 2/
Remarkably, our vaccines do this in some people! That's worth celebrating, but it's the wrong goalpost to have in most cases.
That said, our vaccines are still REDUCING infection and transmission, even if they're not stamping it out. 3/
I laid out some of my thinking process for masking again indoors, in the age of Delta. This is my own personal risk calculation, but I hope it's helpful for some other folks who are puzzling this over. 2/
There's no *one right answer*—rather, everyone has to think about their own local conditions: hospitalizations, vaccination rates, variant prevalence, etc. But it would serve us all to be flexible. This pandemic isn't over. And I don't want to lose the momentum we've built. 3/
I am not an MD, so I’ll offer just this: it’s very encouraging to see federal regulators take swift action on the J&J vaccine. This is the process working as it should. If there is a true link between the vaccine and these rare clots, they will work to identify it. 1/
They may instate an age restriction, as some countries have done for the similar AstraZeneca vaccine—perhaps younger people, especially younger people who are biologically female, may end up needing to seek an alternative. But for now: these cases appear VERY RARE. 2/
So far less than 1 in 1 million. And this DOES NOT detract from the effectiveness of the vaccine, which is excellent.
If you have gotten this vaccine, keep those numbers in mind. All clots also appeared within 2 weeks of injection. 3/